In an interesting debate session at the European Society of Cardiology (ESC) 2022, Dr Carlos Aguiar (Hospital Santa Cruz, Lisbon, Portugal) and Dr John Cleland (University of Glasgow, Glasgow, United Kingdom of Great Britain & Northern Ireland) argued whether to use aspirin in primary and secondary cardiovascular disease (CVD) prevention....
ESC 2022 —Will aspirin stick around in the fight against cardiovascular disease?
Shrabasti Bhattacharya
|
Conference Report
|
31 August 2022
Register or log in to read more
Registration is free and easy, giving you complete access to all Univadis content.
Create a Free Account I have an account